Effect of colchiceine and ursodeoxycholic acid on hepatocyte and erythrocyte membranes and liver histology in experimentally induced carbon tetrachloride cirrhosis in rats

European Journal of Clinical Investigation

Volumn 27, Issue 1, 1997, Pages 77-84

  Nava Ocampo, A A ^a   Suster, S ^b   Muriel, P ^c  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Ca2+ ATPase; Cholesterol phospholipide ratio; Liver damage; Na+,K+ ATPase

Indexed keywords

CHOLESTEROL; COLCHICEINE; PHOSPHOLIPID; URSODEOXYCHOLIC ACID;

ANIMAL MODEL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOCHEMISTRY; ERYTHROCYTE MEMBRANE; HISTOLOGY; LIPID METABOLISM; LIVER CELL; LIVER CIRRHOSIS; LIVER INJURY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0031057344     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.910615.x     Document Type: Article

References (40)

1. Tanner MS, Jackson D, Mowat AP. Hepatic collagen synthesis in a rat model of cirrhosis and its modification by colchicine. J Pathol 1981;135:179-87.
2. Schattner A. Colchicine-expanding horizons. Postgrad Med J 1991;67:223-6.
3. Mourelle M, Fraginals R, Rodríguez L, Favari L, Pérez-Alvares V. Protective effect of colchicine against acute liver damage. Life Sci 1989;45:891-900.
4. Mourelle M, Favari L, Rodríguez L et al. Colchiceine treatment prevents CC14-induced rat liver cirrhosis. Biochem Pharmacol (Life Sci Adv) 1990;9:165-9.
5. Miyaji K, Akiyama T, Ito M et al. Effects of ursodeoxycholic acid on liver function in patients with chronic hepatic diseases - institutional double blind test and a study of the effect on hepatic blood flow (in Japanese). Jpn J Clin Exp Med 1976;53:1395-403.
6. Yamanaka M, Ohto M, Obata H et al. Double blind trial of therapeutic effects of ursodeoxycholic acid on chronic hepatitis (in Japanese). Diagn Treat 1976;64:2150-7.
7. Boyer JL. Definitive therapy for primary biliary cirrhosis: fact or fiction? Gastroenterology 1989;95:242-5.
8. Schuppan D, Kim KY, Riecken EO. Antifibrogenic effect of ursodeoxycholic acid, cyclosporin A, penicillamine, prednisone and colchicine in a rat model of secondary biliary cirrhosis (abstract). Hepatology 1989;10:630.
9. Perdiogoto R, Wiesner RH. Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy. Gastroenterology 1992; 102:1389-91.
10. Ohnishi ST. Importance of biological membranes in disease processes. In: Ohnishi ST, Ohnishi T, eds. Cellular Membrane, a Key to Disease Processes. Florida: CRC Press, 1993: 3-19.
11. Stibler H, Beaugé F, Leguicher A, Borg S. Biophysical and biochemical alterations in erythrocyte membranes from chronic alcoholics. Scand J Clin Lab Invest 1991;195:309-19.
12. Gallagher PG, Tse WT, Forget GB. Clinical and molecular aspects of the erythrocyte membrane skeleton. Semin Perinatol 1990;14:351-67.
13. Levy Y, Leibowitz R, Aviram M, Brook JG, Cogan U. Reduction of plasma cholesterol by lovastatin normalizes erythrocyte membrane fluidity in patients with severe hypercholesterolaemia. Br J Clin Pharmacol 1992;34:427-30.
14. Muriel P, Mourelle M. The role of membrane composition in ATPase activities of cirrhotic rat liver: effect of silymarin. J Appl Toxicol 1990;10:281-4.
15. Popper H, Biandi L, Reutter W. Membrane Alterations as Basis of Liver Injury. England: MTP Press Limited, 1977.
16. Madsen K, Moskalewski S, Thyberg J, Friberg U. Comparison of the in vitro effects of colchicine and its derived colchiceine on chondrocyte morphology and function. Experientia 1979;35:1572-3.
17. Rose HG, Oklander M. Improved procedure for the extraction of lipids from human erythrocytes. J Lipid Res 1965;6:428-31.
18. Neville DM, Jr. Isolation of an organ specific protein from cell surface membrane of rat liver. Biochim Biophys Acta 1968;154:540-52.
19. Pohl SL, Birnbaumer L, Rodbell M. The glucagon sensitive adenyl cyclase system in plasma membranes of rat liver. J Biol Chem 1971;245:1849-56.
20. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497-509.
21. Ames BN. Assay of inorganic phosphate, total phosphate and phosphatases. Methods Enzymol 1966;8:115-18.
22. Abell LL, Levy BB, Brodie BB, Kendall FE. A simplified method for the estimation of cholesterol in serum and demonstration of its specificity. J Biol Chem 1952;195:357-66.
23. Lee KS, Au KS. A protein inhibitor of erythrocyte membrane (Ca2+ + Mg2+)-ATPase. Biochim Biophys Acta 1983;742:54-62.
24. Lotersztajn S, Hanoune J, Pecker F. A high affinity calcium-stimulated magnesium-dependent ATPase in rat liver plasma membranes. J Biol Chem 1981;256:11209-15.
25. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248- 54.
26. Ryoo JW, Buschmann RJ. A morphometric analysis of the hypertrophy of experimental liver cirrhosis. Virchows Arch A Pathol Anal 1983;400:173-86.
27. Kendall M. Rank Correlation Methods. Bucks: Charles Griffin & Co, 1975.
28. Heller FR, Martinet JP, Henrion J, Schapira M, Gallez JF. The rationale for using ursodeoxycholic acid in chronic liver disease. Acta Gastro-Enterol Belg 1990;53:402-7.
29. Skou JC. Overview: the Na+, K+-pump. Methods Enzymol 1988;156:1-25.
30. Kilberg MS. Aminoacid transport in isolated rat hepatocytes. J Membr Biol 1982;69:1-12.
31. Iga T, Klaasen CD. Uptake of hepatic glycogenolysis. Physiol Rev 1980;60:1-50.
32. Duhm J, Zicha J. Reversibility and partial reactions of the Na+/ K+ pump of rat erythrocytes. Physiol Bohemoslovaca 1990;39:1-4.
33. Chau-Wong M, Seeman P. The control of membrane-bound Ca2+ by ATP. Biochim Biophys Acta 1971;241:473-82.
34. Muriel P, Mourelle M. The role of membrane composition in ATPase activities of cirrhotic rat liver. Effect of silymarin. J Appl Toxicol 1990;10:281-4.
35. Mourelle M, Franco MT. Erythrocyte deffects precede the onset of CC14-induced liver cirrhosis. Protection by silymarin. Life Sci 1991;48:1083-90.
36. Leoni S P, Luly MT, Mangiantini, S. Spagnuolo. 1982. Effect of free fatty acids and cholesterol in vitro on liver plasma membrane bound enzymes. Experientia, 32:102-4.
37. Yahuaca P, Amaya A, Rojkind M, Mourelle M. Cryptic adenosine triphosphatase activities in plasma membranes of CC14- cirrhotic rats. Its modulation by changes in cholesterol/phospholipid ratios. Lab Invest 1985;53:541-5.
38. Pérez-Tamayo R. Is cirrhosis of the liver experimentally produced by CC14 an adequate model of human cirrhosis? Hepatology 1983;3:112-20.
39. Moore L. Inhibition of liver-microsome calcium pump by in vivo administration of CC14, CHC13 and, 1:1-dichloroethylene (vinyldiene chloride). Biochem Pharmacol 1980;29:2505-11.
40. Owen SJ, Bruckdorfer KR, Day RC, McIntyre N. Decreased erythrocyte membrane fluidity and altered lipid composition. J Lipid Res 1982;23:124-32.